The global controlled-temperature pharmaceutical packaging market is experiencing significant growth
According to research from Research and Markets, this market is expected to reach a value of €15.74 billion by 2028, up from €9.93 billion in 2023. This growth, representing an annual compound growth rate of 9.5%, is largely attributed to the increasing demand for packaging solutions capable of maintaining specific products within defined temperature ranges for predetermined durations.
Packaging technologies and systems
Controlled temperature packaging (TCP) has become an essential element of modern logistics. Historically, the market was dominated by large pallet-sized containers equipped with integrated cooling systems, called active systems. These systems required external power sources or batteries. In contrast, passive systems use phase change materials (PCM) to modulate the temperature. Both types of systems, active and passive, use refrigerants such as dry or wet ice, gel packs, foam bricks, PCM, or liquid nitrogen in combination with insulating packaging to maintain ideal temperature conditions.
Positive innovations in pharmaceutical packaging in the COVID-19 era
The growing global demand for vaccine transport, especially in the context of COVID-19, propelled the controlled temperature packaging market into an expansion phase. The strict storage requirements for these vaccines highlighted the critical importance of maintaining an uninterrupted cold chain. This is an international trend; Europe is expected to play a major role in the controlled temperature packaging landscape, due to the region’s thriving pharmaceutical industry and the increasing demand for precise temperature control.
For more news, click here.